Purified hexameric Epstein-Barr virus-encoded BARF1 protein for measuring anti-BARF1 antibody responses in nasopharyngeal carcinoma patients

Clinical and Vaccine Immunology

Volumn 18, Issue 2, 2011, Pages 298-304

  Hoebe, E K ^a   Hutajulu, S H ^b   Van Beek, J ^a,c   Stevens, S J ^a,d   Paramita, D K ^b   Greijer, A E ^a   Middeldorp, J M ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b GADJAH MADA UNIVERSITY   (Indonesia)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BARF1 PROTEIN; BARF1 PROTEIN ANTIBODY; BIOLOGICAL MARKER; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIGEN BINDING; ARTICLE; ASIAN; BACULOVIRUS; CANCER PATIENT; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; ESCHERICHIA COLI; GENE MUTATION; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOBLOTTING; IMMUNOGENICITY; IMMUNOREACTIVITY; INDONESIA; MAJOR CLINICAL STUDY; NASOPHARYNX CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEIN PURIFICATION; SERUM;

ANTIBODIES, VIRAL; BACULOVIRIDAE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPSTEIN-BARR VIRUS INFECTIONS; ESCHERICHIA COLI; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INDONESIA; NASOPHARYNGEAL NEOPLASMS; RECOMBINANT PROTEINS; VIRAL PROTEINS; VIROLOGY;

EID: 79551481374     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00193-10     Document Type: Article

References (50)

1. Brooks, L., Q. Y. Yao, A. B. Rickinson, and L. S. Young. 1992. Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts. J. Virol. 66:2689-2697.
2. Chang, E. T., and H. O. Adami. 2006. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol. Biomarkers Prev. 15:1765-1777.
3. Chang, M. S., et al. 2005. Cell-cycle regulators, bcl-2 and NF-kappaB in Epstein-Barr virus-positive gastric carcinomas. Int. J. Oncol. 27:1265-1272.
4. Cohen, J. I., and K. Lekstrom. 1999. Epstein-Barr virus BARF1 protein is dispensable for B-cell transformation and inhibits alpha interferon secretion from mononuclear cells. J. Virol. 73:7627-7632.
5. Decaussin, G., F. Sbih-Lammali, M. de Turenne-Tessier, A. Bouguermouh, and T. Ooka. 2000. Expression of BARF1 gene encoded by Epstein-Barr virus in nasopharyngeal carcinoma biopsies. Cancer Res. 60:5584-5588.
6. de Turenne-Tessier, M., P. Jolicoeur, and T. Ooka. 1997. Expression of the protein encoded by Epstein-Barr virus (EBV) BARF1 open reading frame from a recombinant adenovirus system. Virus Res. 52:73-85.
7. de Turenne-Tessier, M., and T. Ooka. 2007. Post-translational modifications of Epstein Barr virus BARF1 oncogene-encoded polypeptide. J. Gen. Virol. 88:2656-2661.
8. Fachiroh, J., et al. 2006. Single-assay combination of Epstein-Barr virus (EBV) E. J. Clin. Microbiol. 44:1459-1467.
9. Fachiroh, J., et al. 2004. Molecular diversity of Epstein-Barr virus IgG and IgA antibody responses in nasopharyngeal carcinoma: a comparison of Indonesian, Chinese, and European subjects. J. Infect. Dis. 190:53-62.
10. Fåhraeus, R., et al. 1988. Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. Int. J. Cancer 42:329-338.
11. Hatfull, G., A. T. Bankier, B. G. Barrell, and P. J. Farrell. 1988. Sequence analysis of Raji Epstein-Barr virus DNA. Virology 164:334-340.
12. Hayes, D. P., et al. 1999. Expression of Epstein-Barr virus (EBV) transcripts encoding homologues to important human proteins in diverse EBV associated diseases. Mol. Pathol. 52:97-103.
13. Houali, K., et al. 2007. A new diagnostic marker for secreted Epstein-Barr virus encoded LMP1 and BARF1 oncoproteins in the serum and saliva of patients with nasopharyngeal carcinoma. Clin. Cancer Res. 13:4993-5000.
14. Hutajulu, S. H., et al. 2010. Conserved mutation of Epstein-Barr virus-encoded BamHI-A Rightward Frame-1 (BARF1) gene in Indonesian nasopharyngeal carcinoma. Infect. Agents Cancer 5:16.
15. Jayasurya, A., B. H. Bay, W. M. Yap, and N. G. Tan. 2000. Lymphocytic infiltration in undifferentiated nasopharyngeal cancer. Arch. Otolaryngol. Head Neck Surg. 126:1329-1332.
16. Klein, G., et al. 1974. Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx. Proc. Natl. Acad. Sci. U. S. A. 71:4737-4741.
17. Li, J., et al. 2007. Functional inactivation of EBV-specific T-lymphocytes in nasopharyngeal carcinoma: implications for tumor immunotherapy. PLoS One 2:e1122.
18. Martorelli, D., et al. 2008. Spontaneous T cell responses to Epstein-Barr virus-encoded BARF1 protein and derived peptides in patients with nasopharyngeal carcinoma: bases for improved immunotherapy. Int. J. Cancer 123:1100-1107.
19. Meij, P., et al. 2002. Identification and prevalence of CD8(+) T-cell responses directed against Epstein-Barr virus-encoded latent membrane protein 1 and latent membrane protein 2. Int. J. Cancer 99:93-99. (Pubitemid 34273204)
20. Meij, P., et al. 1999. Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroup of patients with EBV-associated diseases. J. Infect. Dis. 179:1108-1115.
21. Meij, P., M. B. Vervoort, C. J. Meijer, E. Bloemena, and J. M. Middeldorp. 2000. Production monitoring and purification of EBV encoded latent membrane protein 1 expressed and secreted by recombinant baculovirus infected insect cells. J. Virol. Methods 90:193-204.
22. Middeldorp, J. M., A. A. Brink, A. J. van den Brule, and C. J. Meijer. 2003. Pathogenic roles for Epstein-Barr virus (EBV) gene products in EBV-associated proliferative disorders. Crit. Rev. Oncol. Hematol. 45:1-36.
23. Middeldorp, J. M., and P. Herbrink. 1988. Epstein-Barr virus specific marker molecules for early diagnosis of infectious mononucleosis. J. Virol. Methods 21:133-146.
24. Middeldorp, J. M., and R. H. Meloen. 1988. Epitope-mapping on the Epstein-Barr virus major capsid protein using systematic synthesis of overlapping oligopeptides. J. Virol. Methods 21:147-159.
25. Modrow, S., et al. 1987. Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions. J. Virol. 61:570-578. (Pubitemid 17001757)
26. Ng, M. H., K. H. Chan, S. P. Ng, and Y. S. Zong. 2006. Epstein-Barr virus serology in early detection and screening of nasopharyngeal carcinoma. Ai Zheng 25:250-256.
27. Ooka, T. 2005. Biological role of the BARF1 gene encoded by Epstein-Barr virus, p. 613. In E. S. Robertson (ed.), Epstein-Barr virus. Caister Academic Press, Wymondham, England.
28. Paramita, D. K., et al. 2007. Native early antigen of Epstein-Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma. J. Med. Virol. 79:1710-1721.
29. Raab-Traub, N. 2002. Epstein-Barr virus in the pathogenesis of NPC. Semin. Cancer Biol. 12:431-441.
30. Sall, A., et al. 2004. Mitogenic activity of Epstein-Barr virus-encoded BARF1 protein. Oncogene 23:4938-4944. (Pubitemid 38932166)
31. Seto, E., T. Ooka, J. Middeldorp, and K. Takada. 2008. Reconstitution of nasopharyngeal carcinoma-type EBV infection induces tumorigenicity. Cancer Res. 68:1030-1036. (Pubitemid 351272220)
32. Seto, E., et al. 2005. Epstein-Barr virus (EBV)-encoded BARF1 gene is expressed in nasopharyngeal carcinoma and EBV-associated gastric carcinoma tissues in the absence of lytic gene expression. J. Med. Virol. 76:82-88.
33. Sheng, W., G. Decaussin, A. Ligout, K. Takada, and T. Ooka. 2003. Malignant transformation of Epstein-Barr virus-negative Akata cells by introduction of the BARF1 gene carried by Epstein-Barr virus. J. Virol. 77:3859-3865.
34. Stevens, S. J., et al. 2005. Diagnostic value of measuring Epstein-Barr virus (EBV) DNA load and carcinoma-specific viral mRNA in relation to anti-EBV immunoglobulin A (IgA) and IgG antibody levels in blood of nasopharyngeal carcinoma patients from Indonesia. J. Clin. Microbiol. 43:3066-3073.
35. Stevens, S. J., et al. 2006. Noninvasive diagnosis of nasopharyngeal carcinoma: nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA. Int. J. Cancer 119:608-614.
36. Strockbine, L. D., et al. 1998. The Epstein-Barr virus BARF1 gene encodes a novel, soluble colony-stimulating factor-1 receptor. J. Virol. 72:4015-4021.
37. Tanner, J. E., et al. 1997. Antibody and antibody-dependent cellular cytotoxicity responses against the BamHI A rightward open-reading frame-1 protein of Epstein-Barr virus (EBV) in EBV-associated disorders. J. Infect. Dis. 175:38-46.
38. Tarbouriech, N., F. Ruggiero, M. de Turenne-Tessier, T. Ooka, and W. P. Burmeister. 2006. Structure of the Epstein-Barr virus oncogene BARF1. J. Mol. Biol. 359:667-678.
39. van Grunsven, W. M., A. Nabbe, and J. M. Middeldorp. 1993. Identification and molecular characterization of two diagnostically relevant marker proteins of the Epstein-Barr virus capsid antigen complex. J. Med. Virol. 40: 161-169.
40. van Grunsven, W. M., W. J. Spaan, and J. M. Middeldorp. 1994. Localization and diagnostic application of immunodominant domains of the BFRF3-encoded Epstein-Barr virus capsid protein. J. Infect. Dis. 170:13-19.
41. Verschuuren, E. A., et al. 2002. Treatment of posttransplant lymphoproliferative disease with rituximab: the remission, the relapse, and the complication. Transplantation 73:100-104.
42. Wang, Q., et al. 2006. Anti-apoptotic role of BARF1 in gastric cancer cells. Cancer Lett. 238:90-103.
43. Wang, Y., B. Luo, P. Zhao, and B. H. Huang. 2004. Expression of Epstein-Barr virus genes in EBV-associated gastric carcinoma. Ai Zheng 23:782-787.
44. Wei, M. X., M. de Turenne-Tessier, G. Decaussin, G. Benet, and T. Ooka. 1997. Establishment of a monkey kidney epithelial cell line with the BARF1 open reading frame from Epstein-Barr virus. Oncogene 14:3073-3081.
45. Wei, M. X., J. C. Moulin, G. Decaussin, F. Berger, and T. Ooka. 1994. Expression and tumorigenicity of the Epstein-Barr virus BARF1 gene in human Louckes B-lymphocyte cell line. Cancer Res. 54:1843-1848.
46. Young, L. S., et al. 1988. Epstein-Barr virus gene expression in nasopharyngeal carcinoma. J. Gen. Virol. 69:1051-1065.
47. Young, L. S., and A. B. Rickinson. 2004. Epstein-Barr virus: 40 years on. Nat. Rev. Cancer 4:757-768.
48. Yu, M. C., J. H. Ho, S. H. Lai, and B. E. Henderson. 1986. Cantonese-style salted fish as a cause of nasopharyngeal carcinoma: report of a case-control study in Hong Kong. Cancer Res. 46:956-961.
49. Zheng, X., L. Hu, F. Chen, and B. Christensson. 1994. Expression of Ki67 antigen, epidermal growth factor receptor and Epstein-Barr virus-encoded latent membrane protein (LMP1) in nasopharyngeal carcinoma. Eur. J. Cancer B Oral Oncol. 30B:290-295.
50. zur Hausen. A., et al. 2000. Unique transcription pattern of Epstein-Barr virus (EBV) in EBV-carrying gastric adenocarcinomas: expression of the transforming BARF1 gene. Cancer Res. 60:2745-2748.